Literature DB >> 13718825

Guanethidine as the sole agent in the treatment of hypertension.

G R CUMMING, B SWAIN.   

Abstract

Entities:  

Keywords:  AMIDINES/therapy; HYPERTENSION/therapy

Mesh:

Substances:

Year:  1961        PMID: 13718825      PMCID: PMC1939190     

Source DB:  PubMed          Journal:  Can Med Assoc J        ISSN: 0008-4409            Impact factor:   8.262


× No keyword cloud information.
  7 in total

1.  A new, potent antihypertensive drug: preliminary study of [2-(octahydro-1-azocinyl)-ethyl]-guanidine sulfate (guanethidine).

Authors:  I H PAGE; H P DUSTAN
Journal:  J Am Med Assoc       Date:  1959-07-11

2.  Bretylium tosylate in the treatment of hypertension.

Authors:  C T DOLLERY; D EMSLIE-SMITH; J McMICHAEL
Journal:  Lancet       Date:  1960-02-06       Impact factor: 79.321

3.  Studies on a new hypotensive agent: bretylium tosylate.

Authors:  J GENEST; G DUFAULT; G PIGEON; J DAVIGNON; P BIRON; J TRUDEL
Journal:  Can Med Assoc J       Date:  1960-04-23       Impact factor: 8.262

4.  Current status of bretylium and guanethidine as antihypertensive drugs.

Authors:  I H PAGE; H P DUSTAN
Journal:  Circulation       Date:  1960-08       Impact factor: 29.690

5.  Clinical experience with bretylium tosylate.

Authors:  J A LEWIS
Journal:  Can Med Assoc J       Date:  1960-04-23       Impact factor: 8.262

6.  The effectiveness of long-term treatment of malignant hypertension.

Authors:  H P DUSTAN; R E SCHNECKLOTH; A C CORCORAN; I H PAGE
Journal:  Circulation       Date:  1958-10       Impact factor: 29.690

7.  Acute and chronic cardiovascular effects of pentolinium in hypertensive patients.

Authors:  S W HOOBLER; J R SMITH
Journal:  Circulation       Date:  1956-12       Impact factor: 29.690

  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.